{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:30:58Z","timestamp":1762101058086},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2407-10-249","type":"journal-article","created":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T18:14:48Z","timestamp":1275416088000},"source":"Crossref","is-referenced-by-count":17,"title":["Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop"],"prefix":"10.1186","volume":"10","author":[{"given":"Mattias K","family":"Andersson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melker","family":"G\u00f6ransson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"\u00c5man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,1]]},"reference":[{"key":"2048_CR1","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone","author":"CDM Fletcher","year":"2002","unstructured":"Fletcher CDM, Unni KK, Mertens F: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. 2002, IARC Press: Lyon"},{"key":"2048_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2121-9-37","volume":"9","author":"MK Andersson","year":"2008","unstructured":"Andersson MK, Stahlberg A, Arvidsson Y, Olofsson A, Semb H, Stenman G, Nilsson O, Aman P: The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 2008, 9: 37-10.1186\/1471-2121-9-37.","journal-title":"BMC Cell Biol"},{"issue":"4","key":"2048_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/gcc.2870050403","volume":"5","author":"P Aman","year":"1992","unstructured":"Aman P, Ron D, Mandahl N, Fioretos T, Heim S, Arheden K, Willen H, Rydholm A, Mitelman F: Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer. 1992, 5 (4): 278-285. 10.1002\/gcc.2870050403.","journal-title":"Genes Chromosomes Cancer"},{"issue":"6430","key":"2048_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/363640a0","volume":"363","author":"A Crozat","year":"1993","unstructured":"Crozat A, Aman P, Mandahl N, Ron D: Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature. 1993, 363 (6430): 640-644. 10.1038\/363640a0.","journal-title":"Nature"},{"issue":"2","key":"2048_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ng0693-175","volume":"4","author":"TH Rabbitts","year":"1993","unstructured":"Rabbitts TH, Forster A, Larson R, Nathan P: Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet. 1993, 4 (2): 175-180. 10.1038\/ng0693-175.","journal-title":"Nat Genet"},{"issue":"3","key":"2048_CR6","first-page":"489","volume":"12","author":"I Panagopoulos","year":"1996","unstructured":"Panagopoulos I, Hoglund M, Mertens F, Mandahl N, Mitelman F, Aman P: Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene. 1996, 12 (3): 489-494.","journal-title":"Oncogene"},{"issue":"20","key":"2048_CR7","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/sj.onc.1203572","volume":"19","author":"J Perez-Losada","year":"2000","unstructured":"Perez-Losada J, Pintado B, Gutierrez-Adan A, Flores T, Banares-Gonzalez B, del Campo JC, Martin-Martin JF, Battaner E, Sanchez-Garcia I: The chimeric FUS\/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene. 2000, 19 (20): 2413-2422. 10.1038\/sj.onc.1203572.","journal-title":"Oncogene"},{"issue":"5","key":"2048_CR8","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.2353\/ajpath.2006.050872","volume":"168","author":"K Engstrom","year":"2006","unstructured":"Engstrom K, Willen H, Kabjorn-Gustafsson C, Andersson C, Olsson M, Goransson M, Jarnum S, Olofsson A, Warnhammar E, Aman P: The myxoid\/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells. Am J Pathol. 2006, 168 (5): 1642-1653. 10.2353\/ajpath.2006.050872.","journal-title":"Am J Pathol"},{"issue":"14","key":"2048_CR9","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1158\/0008-5472.CAN-05-3979","volume":"66","author":"N Riggi","year":"2006","unstructured":"Riggi N, Cironi L, Provero P, Suva ML, Stehle JC, Baumer K, Guillou L, Stamenkovic I: Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res. 2006, 66 (14): 7016-7023. 10.1158\/0008-5472.CAN-05-3979.","journal-title":"Cancer Res"},{"issue":"17","key":"2048_CR10","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1073\/pnas.91.17.7869","volume":"91","author":"I Sanchez-Garcia","year":"1994","unstructured":"Sanchez-Garcia I, Rabbitts TH: Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proc Natl Acad Sci USA. 1994, 91 (17): 7869-7873. 10.1073\/pnas.91.17.7869.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2048_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<30::AID-IJC6>3.0.CO;2-4","volume":"83","author":"S Thelin-Jarnum","year":"1999","unstructured":"Thelin-Jarnum S, Lassen C, Panagopoulos I, Mandahl N, Aman P: Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas. Int J Cancer. 1999, 83 (1): 30-33. 10.1002\/(SICI)1097-0215(19990924)83:1<30::AID-IJC6>3.0.CO;2-4.","journal-title":"Int J Cancer"},{"issue":"54","key":"2048_CR12","doi-asserted-by":"publisher","first-page":"8025","DOI":"10.1038\/sj.onc.1208939","volume":"24","author":"MF Gee","year":"2005","unstructured":"Gee MF, Tsuchida R, Eichler-Jonsson C, Das B, Baruchel S, Malkin D: Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Oncogene. 2005, 24 (54): 8025-8037. 10.1038\/sj.onc.1208939.","journal-title":"Oncogene"},{"issue":"9","key":"2048_CR13","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1096\/fj.05-5678fje","volume":"20","author":"M Jernas","year":"2006","unstructured":"Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjogren A, Rudemo M, Lystig TC, et al: Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J. 2006, 20 (9): 1540-1542. 10.1096\/fj.05-5678fje.","journal-title":"FASEB J"},{"issue":"7","key":"2048_CR14","doi-asserted-by":"publisher","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3 (7): RESEARCH0034-10.1186\/gb-2002-3-7-research0034.","journal-title":"Genome Biol"},{"issue":"5","key":"2048_CR15","first-page":"1349","volume":"25","author":"A Olofsson","year":"2004","unstructured":"Olofsson A, Willen H, Goransson M, Engstrom K, Meis-Kindblom JM, Stenman G, Kindblom LG, Aman P: Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas. Int J Oncol. 2004, 25 (5): 1349-1355.","journal-title":"Int J Oncol"},{"issue":"7","key":"2048_CR16","doi-asserted-by":"publisher","first-page":"e2569","DOI":"10.1371\/journal.pone.0002569","volume":"3","author":"PA Perez-Mancera","year":"2008","unstructured":"Perez-Mancera PA, Bermejo-Rodriguez C, Sanchez-Martin M, Abollo-Jimenez F, Pintado B, Sanchez-Garcia I: FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C\/EBPalpha and activating eIF4E. PLoS ONE. 2008, 3 (7): e2569-10.1371\/journal.pone.0002569.","journal-title":"PLoS ONE"},{"issue":"1","key":"2048_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/hupa.2001.21139","volume":"32","author":"S Nagura","year":"2001","unstructured":"Nagura S, Katoh R, Miyagi E, Shibuya M, Kawaoi A: Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density. Hum Pathol. 2001, 32 (1): 10-17. 10.1053\/hupa.2001.21139.","journal-title":"Hum Pathol"},{"issue":"4","key":"2048_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<369::AID-PATH381>3.0.CO;2-X","volume":"188","author":"M Decaussin","year":"1999","unstructured":"Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C, Brambilla E: Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1\/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. J Pathol. 1999, 188 (4): 369-377. 10.1002\/(SICI)1096-9896(199908)188:4<369::AID-PATH381>3.0.CO;2-X.","journal-title":"J Pathol"},{"issue":"3","key":"2048_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/cdd.2009.152","volume":"17","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Neiva KG, Lingen MW, Ellis LM, Nor JE: VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ. 2010, 17 (3): 499-512. 10.1038\/cdd.2009.152.","journal-title":"Cell Death Differ"},{"key":"2048_CR20","unstructured":"Lo HW, Hung MC: Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer. 2007, R16-20. 96 Suppl"},{"issue":"1","key":"2048_CR21","first-page":"339","volume":"142","author":"R Matsuda","year":"1993","unstructured":"Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, Seito T, Sugiura T, Ariyoshi Y, et al: Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol. 1993, 142 (1): 339-346.","journal-title":"Am J Pathol"},{"issue":"1","key":"2048_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0169-328X(96)00010-1","volume":"38","author":"MK Stachowiak","year":"1996","unstructured":"Stachowiak MK, Maher PA, Joy A, Mordechai E, Stachowiak EK: Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. Brain Res Mol Brain Res. 1996, 38 (1): 161-165. 10.1016\/0169-328X(96)00010-1.","journal-title":"Brain Res Mol Brain Res"},{"issue":"3","key":"2048_CR23","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1006\/bbrc.1994.2368","volume":"203","author":"Y Xie","year":"1994","unstructured":"Xie Y, Hung MC: Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. Biochem Biophys Res Commun. 1994, 203 (3): 1589-1598. 10.1006\/bbrc.1994.2368.","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"2048_CR24","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1158\/0008-5472.CAN-04-4575","volume":"65","author":"B Das","year":"2005","unstructured":"Das B, Yeger H, Tsuchida R, Torkin R, Gee MF, Thorner PS, Shibuya M, Malkin D, Baruchel S: A hypoxia-driven vascular endothelial growth factor\/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase\/extracellular signal-regulated kinase 1\/2 pathway in neuroblastoma. Cancer Res. 2005, 65 (16): 7267-7275. 10.1158\/0008-5472.CAN-04-4575.","journal-title":"Cancer Res"},{"issue":"5","key":"2048_CR25","first-page":"249","volume":"24","author":"Y Wang","year":"2003","unstructured":"Wang Y, Xiao ZJ, Liu P, Yang C, Yang RC, Cai YL, Han ZC: Expression of vascular endothelial growth factor and its receptors KDR and Flt1 in acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi. 2003, 24 (5): 249-252.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"4","key":"2048_CR26","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1182\/blood-2002-07-2184","volume":"101","author":"I Casella","year":"2003","unstructured":"Casella I, Feccia T, Chelucci C, Samoggia P, Castelli G, Guerriero R, Parolini I, Petrucci E, Pelosi E, Morsilli O, et al: Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. Blood. 2003, 101 (4): 1316-1323. 10.1182\/blood-2002-07-2184.","journal-title":"Blood"},{"issue":"5","key":"2048_CR27","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1359\/jbmr.080103","volume":"23","author":"KA Jacobsen","year":"2008","unstructured":"Jacobsen KA, Al-Aql ZS, Wan C, Fitch JL, Stapleton SN, Mason ZD, Cole RM, Gilbert SR, Clemens TL, Morgan EF, et al: Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling. J Bone Miner Res. 2008, 23 (5): 596-609. 10.1359\/jbmr.080103.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2048_CR28","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1371\/journal.pmed.0040186","volume":"4","author":"TH Lee","year":"2007","unstructured":"Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, Avraham S: Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1\/FLT1. PLoS Med. 2007, 4 (6): e186-10.1371\/journal.pmed.0040186.","journal-title":"PLoS Med"},{"issue":"2","key":"2048_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/onc.2008.378","volume":"28","author":"M Goransson","year":"2009","unstructured":"Goransson M, Andersson MK, Forni C, Stahlberg A, Andersson C, Olofsson A, Mantovani R, Aman P: The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ. Oncogene. 2009, 28 (2): 270-8. 10.1038\/onc.2008.378.","journal-title":"Oncogene"},{"issue":"18","key":"2048_CR30","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1016\/S0960-894X(03)00626-7","volume":"13","author":"P Furet","year":"2003","unstructured":"Furet P, Bold G, Hofmann F, Manley P, Meyer T, Altmann KH: Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching. Bioorg Med Chem Lett. 2003, 13 (18): 2967-2971. 10.1016\/S0960-894X(03)00626-7.","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"2048_CR31","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1158\/1535-7163.1639.3.12","volume":"3","author":"K Nakamura","year":"2004","unstructured":"Nakamura K, Yamamoto A, Kamishohara M, Takahashi K, Taguchi E, Miura T, Kubo K, Shibuya M, Isoe T: KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth. Mol Cancer Ther. 2004, 3 (12): 1639-1649.","journal-title":"Mol Cancer Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-249\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T05:47:33Z","timestamp":1711518453000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2048"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-249","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,1]]},"article-number":"249"}}